Lonza · 8 hours ago
Operational Excellence Intern
Lonza is a global leader in the life sciences sector, and they are seeking an Operational Excellence Intern to join their team. This internship offers hands-on experience in optimizing manufacturing operations and contributing to various projects within the pharmaceutical manufacturing site.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Assist in process improvement projects to enhance manufacturing efficiency and reduce waste
Support the implementation of lean principles and continuous improvement methodologies
Collaborate with cross-functional teams to optimize production processes and ensure product quality
Gain exposure to various manufacturing technologies and equipment
Participate in data analysis and problem-solving activities and Support Value Stream Mapping Events
Contribute to the development of training materials and supporting training on Lean methodologies, kaizen events, and Lean White/Yellow Belt Trainings
Support Lean Manufacturing Project
Support teams with Huddles, KPIs and Fabriq Board deployment
Qualification
Required
Completion of junior year (typically 90 credits) towards a B.S. degree in a related field
Minimum cumulative GPA of 3.0 (out of 4) required
Must currently be enrolled in BS or MS Academic Program
Problem solving and team collaboration
Attention to detail and commitment to quality and safety
Ability to follow procedures and guidance in a regulated environment
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase